Orforglipron Lowers A1c, Weight in Early Type 2 Diabetes

Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, investigator says.
Medscape Medical News

source https://www.medscape.com/viewarticle/orforglipron-lowers-a1c-weight-early-type-2-diabetes-2025a1000gln?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension